期刊文献+

临床宫颈组织标本HPV16 L1蛋白检测 被引量:3

The detection of HPV16 L1 from cervical tissue specimen
下载PDF
导出
摘要 目的检测HPV16阳性宫颈标本L1蛋白的表达,研究宫颈损伤程度与L1蛋白表达的规律。方法应用PCR法对宫颈炎、宫颈上皮内瘤变(CINⅠ~Ⅱ)、原位癌、早期浸润癌及中晚期癌标本进行型别检测,ELISA法及免疫组化法检测HPV16阳性标本中HPV L1蛋白表达。结果 54例宫颈组织中HPV16阳性为46例(85.2%)。随着宫颈损伤加重,HPV16阳性标本的抗原抗体反应逐渐减弱;免疫组化阳性反应仅出现于上皮组织内,反应强度及分布与宫颈损伤程度及癌变组织的分化状态有关。结论 HPV16 L1蛋白的表达同时受宫颈组织损伤程度及宿主细胞分化状态的影响。早期对HPV L1蛋白进行检测,可为宫颈癌的早期预防及临床诊治提供理论指导。 Objective Detecting the expression of L1 in HPV16 infected cervical tissues and explore the correlation of HPV16 L1 with cervix injured degree.Methods Multiplex PCR was used to detect HPV16-positive specimen in cervicitis,CINⅠ~Ⅱ,cancer in situ and cervical cancer.The expression of L1 was detected in each group by ELISA and immunohistochemistry.Results Forty-six of 54 cases were HPV16 positive(85.2%).The reaction between antigen and antibody get less significant as the aggravation of cervical damage;the positive reaction appeared in the epithelium tissue in immunohistochemistry,which was effected by tissue's damaged degree and differentiated states.Conclusion Higher rate of HPV16 detection in women.L1 expressed in epithelium which affected by tissue's differentiation.The expression of HPV16 L1 was less significant with as the damage aggravation.Detecting HPV L1 earlier in clinic can provide the direction for cervical cancer.
出处 《基础医学与临床》 CSCD 北大核心 2010年第8期807-810,共4页 Basic and Clinical Medicine
基金 湖北省教育厅重大课题([2007]4号Z200713002) 湖北省卫生厅科研基金(鄂卫发[2006]97号JX3B32) 国家自然科学基金面上项目(307770104)
关键词 人乳头瘤病毒 宫颈癌 外壳蛋白L1 聚合酶链式反应 免疫组化 human papillomavirus cervical carcinoma capsid protein L1 PCR immunohistochemistry
  • 相关文献

参考文献9

  • 1Cain JM, Howett MK. Preventing cervical cancer[J]. Science, 2000, 288 (5472) : 1753 - 1754.
  • 2Tay SK, Ngan HY, Chu TY, et al. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan [ J ]. Vaccine, 2008, 26(12):60-70.
  • 3Liu SS, Tsang PC, Chan KY, et al. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas [ J ]. Tumour Biol, 2008, 29 (2) : 105 - 113.
  • 4Kulmala SM, Syrjanen SM, Gyllensten UB, et al. Early integration of high copy HPV16 detectable in women with norreal and low grade cervical cytology and histology [ J]. J Clin Pathol, 2006, 59(5) :513 -517.
  • 5Anhang R, Goodman A, Goldie SJ. HPV Communication:review of existing research and recommendations for patient education[J]. CA Cancer J Clin, 2004, 54(5) :248 -259.
  • 6潘凌亚.HPV感染与宫颈癌前病变[J].基础医学与临床,2006,26(12):1296-1301. 被引量:26
  • 7Peh WL, Middleton K, Christensen N, et al. Life cycle heterogeneity in animal models of human papillomavirus-associated disease [ J]. J Virol, 2002, 76 (20) : 10401 - 10416.
  • 8Middleton K, Peh W, Southern SA, et al. Organisation of the human papillomavirus productive cycle during neoplastic progression provides a basis for the selection of diagnostic markers[ J]. J Virol, 2003, 77 (19) : 10186 - 10201.
  • 9Wu TC, Hsieh ST, Purow BW, et al. Demonstration of human papillomavirus (HPV) genomic amplification and viral-like particles from CaSki cell line in SCID mice [ J ]. J Virol, 1997, 65(2) :287 -298.

二级参考文献36

  • 1Richart RM. Cervical intraepithelial neoplasia: a review[M]//Sommers SC. Pathology Annual. New York: Appleton- Century- Crofts, 1973:301 -328.
  • 2Koutsky LA, Kiviat NB. C, enital human papillomavirus [M]//K Holmes, P Mardh, P Sparling, et al. Sexually Transmitted Diseases. 3rd ed. New York: McGraw- Hill,1999:347 - 359.
  • 3Wright TC Jr, Denny L, Kuhn L, et al. HPV DNA testing of self- collected vaginal samples compared with cytologic screening to detect cervical cancer[J].JAMA, 2000, 283(1) :81 -86.
  • 4Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia. Using human papillomavirus DNA testing for equivocal papanicolaou results[J]. JAMA, 1999, 281:1605 - 1610.
  • 5zur Hausen H. Papillomaviruses and cancer: From basis studies to clinical application[J]. Nut Rev Cancer, 2002,2:342 - 350.
  • 6Wemess BA, Levine A J, Howley PM. Association of human papillomavirus types 16 and 18 E6 protein with p53 [J]. Science, 1990, 248:76-79.
  • 7Scheffner M, Wemess BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human paillomavirus types 16 and 18promotes the degradation of p53 [J]. Cell, 1990, 63:1129 -1136.
  • 8Klingethutz A J, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of uman papillomavirus type 16[J]. Nature, 1996, 380:79 -82.
  • 9Waggoner S, Cherniky CL. Molecular biology of cervical and vulvar carcinoma [M]// Gershenson DM, McGuire WP, Gore M, et al. Gynecologic Cancer: Controversies in Management. Philadephia: Elsevier Churchill Livingstone,2004: pp65 - 78.
  • 10Chellappan S, Kraus VB, Kroger B, et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papilomavirus E7 protein share the capacity to disrupt the interaction between the transcription factor E2F and the retinoblastoma gene product [ J ]. Proc Natl Acad Sci USA,1992, 89:4549 -4553.

共引文献25

同被引文献44

  • 1姜波玲,肖长义,袁太宁,叶红,王雅琴,黎家华,黄利鸣.HPV L1 C-末端保守序列短肽体液免疫学特性[J].免疫学杂志,2009,25(3):239-242. 被引量:5
  • 2杨军,王一理,司履生.HPV16L1核浆运输的动力学过程[J].微生物学报,2006,46(6):917-921. 被引量:2
  • 3Macville M, Schrock E, Padilla-Nash H et al. Comprehensive and definitive molecular cytogenetic characterization of HeLa ceils by spectral karyotyping[ J]. Cancer Res, 1999 ;59( 1 ) :141-150.
  • 4Boshartb M, Gissmann L, Ikenberg H et al. A new type of papilloma- virus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer [ J ]. E MBO J, 1984 ;3 (5) : 1151-1157.
  • 5Wright T C, Massad L S, Dunton C J et al. 2006 Consensus guide- lines for the management of women with abnormal cervical cancer screening tests [ J]. Am J Obstet Gynecol, 2007 ; 197 (4) :346-355.
  • 6Future II Study Group. Quadrivalent vaccine against human papilloma- virus to prevent high grade cervical lesions[J]. N Engl J Med, 2007 ; 356(19) :1915-1927.
  • 7Villa L L, Schlegel R. Differences in transformation activity between HPV 18 and HPV 16 map to the viral LCR E6 E7 region[J]. Virolo- gy, 1991 ;181(1) : 374-377.
  • 8Zur Hausen H. Virus in human cancers[J]. Science, 1990;254:1167.
  • 9Kurman R J, Schiffman M H, Lancaster W D et al. Analysis of indi- vidual HPV types in cervical neoplasia: a possible role for type 18 in rapid progression [ J ]. Am J Obstet Gynecol, 1988 ; 195 ( 2 ) : 293 -296.
  • 10Boshart M, Gissmann L, Ikenberg H et al. A new type of papilloma- virus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical eancer[J]. EMBO J, 1984;3(5) :1151-1157.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部